1.
Zakir AA, Mohd Siddique MU. #165 Design and synthesis of allosteric fourth-generation EGFR tyrosine kinase triple mutant selective inhibitors for the treatment of non-small cell lung cancer. J Pharm Chem [Internet]. 2022 Jul. 20 [cited 2022 Dec. 3];8(Supplement). Available from: https://pubs.vensel.org/index.php/jphchem/article/view/258